Washington, DC 20006-5349
HELPLINE
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
With only one FDA-approved treatment for mesothelioma (a chemotherapy combination of Alimta (pemetrexed) and cisplatin), most advances in mesothelioma treatment are still considered experimental. As
Mesothelioma is not lung cancer, but many experts who treat mesothelioma also treat lung cancer. Therefore, this enormous conference which often boasts 7,000 to 8,000
We are deeply saddened by the passing of Dr. David Sugarbaker, a beloved mesothelioma surgeon and researcher. He leaves a huge void in the mesothelioma
On August 26, Mary Hesdorffer, NP, executive director of the Mesothelioma Applied Research Foundation, and Heather Von St. James, a mesothelioma warrior and advocate, were
The Bruce A. Waite 5K celebrates seven years fighting back against mesothelioma and honoring the life of former Mansfield Senior High School teacher (1959-1989), Bruce
Today, the Meso Foundation wrote a letter to the acting administrator of the EPA urging the agency to account for legacy asbestos when evaluating asbestos
We have exciting news! The next stop on the 2018 International Symposium on Malignant Mesothelioma tour is New York City on Friday, Oct. 5, 2018,
Effective today, Aug. 1, the Meso Foundation’s new office location will be 1615 L Street NW, Suite 430, Washington, D.C. 20036. Our office numbers will
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
